Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma

This publication has 17 references indexed in Scilit:

• “Low-Grade Leiomyosarcoma” and Late-Recurring Smooth Muscle Tumors of the Uterus
  American Journal of Surgical Pathology, 2011
• Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors
  Gynecologic Oncology, 2010
• Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems
  Journal of Clinical Oncology, 2009
• FIGO staging for uterine sarcomas
  International Journal of Gynecology & Obstetrics, 2009
• Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
  European Journal of Cancer, 2008
• Mifepristone as Treatment of Recurrent Progesterone Receptor–Positive Uterine Leiomyosarcoma
  Obstetrics & Gynecology, 2007
• Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma
  Cancer, 2004
• Malignant Neoplasms of the Uterine Corpus in Patients Treated for Breast Carcinoma: The Effects of Tamoxifen
  International Journal of Gynecological Pathology, 1994
• Problematic Uterine Smooth Muscle Neoplasms
  American Journal of Surgical Pathology, 1994
• Uterine sarcoma: Steroid receptors and response to hormonal therapy
  Gynecologic Oncology, 1990